Short answer
Incorporate additive manufacturing, particularly FFF and SSE, into the design process for medical devices and drug delivery systems to enable true personalization and optimize patient treatment.
- Field
- Commercial Production
- Source
- Molecules (2022)
- Method
- Literature Review
- Evidence
- Strong effect
Additive manufacturing techniques like Fused Filament Fabrication (FFF) and Semi-Solid Extrusion (SSE) allow for the precise, on-demand creation of personalized drug delivery systems and medical devices. This commercial production research insight is drawn from a 2022 study published in Molecules. Using Literature review, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Incorporate additive manufacturing, particularly FFF and SSE, into the design process for medical devices and drug delivery systems to enable true personalization and optimize patient treatment.
3D Printing Enables Personalized Medicine with Tailored Drug Delivery
Additive manufacturing techniques like Fused Filament Fabrication (FFF) and Semi-Solid Extrusion (SSE) allow for the precise, on-demand creation of personalized drug delivery systems and medical devices.
Molecules · 2022
Key Findings
- 01FFF and SSE are versatile, precise, and cost-effective 3D printing methods for personalized medical products.
- 02These techniques allow for patient-tailored drug dosages, forms, and release profiles.
- 03Critical printing parameters and material selection are key to achieving desired product functionality.
Application
Design takeaway
Incorporate additive manufacturing, particularly FFF and SSE, into the design process for medical devices and drug delivery systems to enable true personalization and optimize patient treatment.
How to apply
When designing a medical device or a drug delivery system, consider how FFF or SSE could be used to customize the product for an individual user's anatomy, physiology, or treatment regimen.
Project actions
- 01Explore how FFF or SSE could be used to create a custom medical device or a unique drug dosage form.
- 02Investigate the material properties required for biocompatibility and controlled release in 3D printed pharmaceuticals.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Comprehensive review of extrusion-based AM for medical applications.
- +Highlights practical aspects like parameters, materials, and limitations.
Limitations
The cost and scalability of personalized 3D printed pharmaceuticals for widespread clinical use remain challenges.
Reliability & validity
The validity of this review relies on the quality and breadth of the literature surveyed. The findings are generalizable to extrusion-based 3D printing but may not apply to other AM technologies. Reliability is based on the consistent reporting of findings across multiple studies.
Think critically
Beyond the technical feasibility, what are the ethical and regulatory considerations for widespread adoption of personalized 3D printed pharmaceuticals?
Design Principles
"Design for personalization through additive manufacturing to meet unique user needs."
This capability shifts pharmaceutical and medical device production from mass manufacturing to highly individualized solutions. Designers can now create products optimized for specific patient needs, improving therapeutic outcomes and patient compliance.
What This Means for Your Design
3D printing can make medicines and medical tools just for one person, changing the dose or shape to help them better.
How to use in your project
- 1.Reference this paper when discussing the potential of additive manufacturing for creating personalized medical products or drug delivery systems in your design project.
Add to My Project
Quick Cite
Paragraph starter
Additive manufacturing techniques, specifically Fused Filament Fabrication (FFF) and Semi-Solid Extrusion (SSE), offer significant potential for the development of personalized drug delivery systems and medical devices. These extrusion-based 3D printing methods allow for precise control over product design, enabling tailored drug dosages, release profiles, and device geometries to meet individual patient needs, thereby enhancing therapeutic efficacy and patient outcomes.
Source
Molecules
Additive Manufacturing Strategies for Personalized Drug Delivery Systems and Medical Devices: Fused Filament Fabrication and Semi Solid Extrusion
journal · 2022
View sourceQuestions About This Research
- What does the research say about 3d printing enables personalized medicine with tailored drug delivery?
- Incorporate additive manufacturing, particularly FFF and SSE, into the design process for medical devices and drug delivery systems to enable true personalization and optimize patient treatment. Evidence: Molecules (2022).
- Why does "3D Printing Enables Personalized Medicine with Tailored Drug Delivery" matter for design?
- This capability shifts pharmaceutical and medical device production from mass manufacturing to highly individualized solutions. Designers can now create products optimized for specific patient needs, improving therapeutic outcomes and patient compliance.
- How can designers apply this research?
- Incorporate additive manufacturing, particularly FFF and SSE, into the design process for medical devices and drug delivery systems to enable true personalization and optimize patient treatment.
- What were the main findings?
- FFF and SSE are versatile, precise, and cost-effective 3D printing methods for personalized medical products.. These techniques allow for patient-tailored drug dosages, forms, and release profiles.. Critical printing parameters and material selection are key to achieving desired product functionality.
- What research method was used?
- Literature Review.
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2022 journal from Molecules.
- What should I do differently in my next project?
- When designing a medical device or a drug delivery system, consider how FFF or SSE could be used to customize the product for an individual user's anatomy, physiology, or treatment regimen.
- What are the limitations?
- The review focuses on extrusion-based methods and may not cover all AM techniques applicable to personalized medicine. Clinical translation and regulatory hurdles are significant considerations not fully detailed.